RANI THERAPEUTICS HOLDINGS INC. - CLASS A COMMON
2.0800
25-November-24 12:30:12
15 minutes delayed
Stocks
0.0000
0.00%
Today's range
2.0600 - 2.1600
ISIN
N/A
Source
NASDAQ
-
Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study
06 Dec 2022 16:05:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
10 Nov 2022 16:05:01 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the Stifel Healthcare Conference
09 Nov 2022 16:05:02 By Nasdaq GlobeNewswire
-
Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update
24 Oct 2022 08:30:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
06 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock
11 Aug 2022 23:47:30 By Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock
10 Aug 2022 17:28:34 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update
10 Aug 2022 16:28:17 By Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis
10 Aug 2022 16:23:29 By Nasdaq GlobeNewswire
-
08 Aug 2022 08:30:00 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update
11 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at Upcoming Investor Conferences
03 May 2022 16:05:01 By Nasdaq GlobeNewswire
-
03 May 2022 07:00:02 By Nasdaq GlobeNewswire
-
Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
07 Apr 2022 16:05:00 By Nasdaq GlobeNewswire
-
29 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
23 Mar 2022 20:38:02 By Nasdaq GlobeNewswire
-
Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis
23 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
23 Feb 2022 08:00:02 By Nasdaq GlobeNewswire
-
Rani Therapeutics Appoints Lisa Rometty to Board of Directors
07 Jan 2022 08:00:01 By Nasdaq GlobeNewswire
-
Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update
15 Nov 2021 19:31:25 By Nasdaq GlobeNewswire